Adherence to inhalers in patients with severe asthma treated with anti-interleukin-5 biologics Paula Granda, Elena Villamañán, Carlos Carpio, Daniel Laorden, Carmen Sobrino, Alicia Herrero, Santiago Quirce, Rodolfo Álvarez-Sala

Economic evaluation and budgetary burden of mepolizumab in severe refractory eosinophilic asthma Leticia García-Mochón, Manuel David Gil-Sierra, Emilio Jesús Alegre-del Rey, Catalina Alarcón de la Lastra-Romero, Marina Sánchez-Hidalgo

Effectiveness and pharmacoeconomic analysis of the treatment of severe asthma with omalizumab in clinical practice Eva Martínez-Moragón, María Climent, Eusebi Chiner, Cleofé Fernández-Aracil, Fernando Sánchez-Toril, Inmaculada Lluch-Tortajada